These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 16051399)

  • 1. The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome--a double blind, placebo-controlled, randomized study.
    Niv E; Naftali T; Hallak R; Vaisman N
    Clin Nutr; 2005 Dec; 24(6):925-31. PubMed ID: 16051399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
    J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactobacillus reuteri DSM 17938 in the Treatment of Functional Abdominal Pain in Children: RCT Study.
    Jadrešin O; Hojsak I; Mišak Z; Kekez AJ; Trbojević T; Ivković L; Kolaček S
    J Pediatr Gastroenterol Nutr; 2017 Jun; 64(6):925-929. PubMed ID: 27906800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effectiveness of Synbiotic Preparation Containing
    Skrzydło-Radomańska B; Prozorow-Król B; Cichoż-Lach H; Majsiak E; Bierła JB; Kosikowski W; Szczerbiński M; Gantzel J; Cukrowska B
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32635661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study.
    Skrzydło-Radomańska B; Prozorow-Król B; Cichoż-Lach H; Majsiak E; Bierła JB; Kanarek E; Sowińska A; Cukrowska B
    Nutrients; 2021 Feb; 13(3):. PubMed ID: 33652763
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Martoni CJ; Srivastava S; Leyer GJ
    Nutrients; 2020 Jan; 12(2):. PubMed ID: 32019158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blinded, placebo-controlled clinical trial on Lactobacillus-containing cultured milk drink as adjuvant therapy for depression in irritable bowel syndrome.
    Sarkawi M; Raja Ali RA; Abdul Wahab N; Abdul Rathi ND; Mokhtar NM
    Sci Rep; 2024 Apr; 14(1):9478. PubMed ID: 38658619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
    Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
    Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial.
    Ojetti V; Ianiro G; Tortora A; D'Angelo G; Di Rienzo TA; Bibbò S; Migneco A; Gasbarrini A
    J Gastrointestin Liver Dis; 2014 Dec; 23(4):387-91. PubMed ID: 25531996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis.
    Didari T; Mozaffari S; Nikfar S; Abdollahi M
    World J Gastroenterol; 2015 Mar; 21(10):3072-84. PubMed ID: 25780308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised controlled trial of a probiotic 'functional food' in the management of irritable bowel syndrome.
    Roberts LM; McCahon D; Holder R; Wilson S; Hobbs FD
    BMC Gastroenterol; 2013 Mar; 13():45. PubMed ID: 23496803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: a randomized, double-blind study.
    Dapoigny M; Piche T; Ducrotte P; Lunaud B; Cardot JM; Bernalier-Donadille A
    World J Gastroenterol; 2012 May; 18(17):2067-75. PubMed ID: 22563194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of
    Lewis ED; Antony JM; Crowley DC; Piano A; Bhardwaj R; Tompkins TA; Evans M
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32326347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life.
    Lorenzo-Zúñiga V; Llop E; Suárez C; Alvarez B; Abreu L; Espadaler J; Serra J
    World J Gastroenterol; 2014 Jul; 20(26):8709-16. PubMed ID: 25024629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome.
    Ishaque SM; Khosruzzaman SM; Ahmed DS; Sah MP
    BMC Gastroenterol; 2018 May; 18(1):71. PubMed ID: 29801486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised clinical trial: A liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome--a 12 week double-blind study.
    Sisson G; Ayis S; Sherwood RA; Bjarnason I
    Aliment Pharmacol Ther; 2014 Jul; 40(1):51-62. PubMed ID: 24815298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescript-Assist probiotic-prebiotic treatment for irritable bowel syndrome: a methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study.
    Bittner AC; Croffut RM; Stranahan MC
    Clin Ther; 2005 Jun; 27(6):755-61. PubMed ID: 16117982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Probiotic Escherichia coli Nissle 1917 in Patients with Irritable Bowel Syndrome: a Double Blind Placebo-controlled Randomized Trial.
    Faghihi AH; Agah S; Masoudi M; Ghafoori SM; Eshraghi A
    Acta Med Indones; 2015 Jul; 47(3):201-8. PubMed ID: 26586385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of New
    Oh JH; Jang YS; Kang D; Chang DK; Min YW
    Nutrients; 2019 Nov; 11(12):. PubMed ID: 31783597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised double blind placebo controlled trial on Lactobacillus reuteri DSM 17938: improvement in symptoms and bowel habit in functional constipation.
    Riezzo G; Orlando A; D'Attoma B; Linsalata M; Martulli M; Russo F
    Benef Microbes; 2018 Jan; 9(1):51-60. PubMed ID: 29022390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.